Clinical Trial Update: Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating amifostine followed by high-dose chemotherapy in patients with hematologic cancers and solid tumors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer
• Lymphoma
• Ovarian Cancer

Drugs mentioned

• ETHYOL (Amifostine)

Snippet

Sponsor: Scripps Health | Conditions: Breast Cancer, Drug/Agent Toxicity by Tissue/Organ | Phase 2 | Status: COMPLETED